For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Mirabilis Medica, Inc.

USPTO Granted Patents = 15

% Expired Patents = 100.0

EPO Patents = 5

Forward Citations = 1,302

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Gregory Paul Darlington (9 out of 21 patents)

Michael J Connolly (8 out of 38 patents)

Justin Reed (6 out of 9 patents)

4. Jessica E Parsons (5 out of 5 patents)

5. Charles Dale Emery (5 out of 14 patents)

6. Michael P H Lau (4 out of 6 patents)

7. Alexander Lebedev (4 out of 10 patents)

8. Roland Horth (4 out of 4 patents)

9. John Russell Murkowski (4 out of 25 patents)

10. Shahram Vaezy (3 out of 21 patents)

11. Barry Friemel (2 out of 16 patents)

12. David C Auth (2 out of 31 patents)

13. Tim Etchells (2 out of 9 patents)

14. Michael William Lau (2 out of 3 patents)

15. Adam Lee Smith (1 out of 45 patents)

15 patents: Sort by Forward Citations

1. 9770605 - System for treating a volume of tissue with high intensity focused ultrasound (2017-09-26),

2. 9675819 - Human interface and device for ultrasound guided treatment (2017-06-13),

3. 9573000 - HIFU applicator (2017-02-21),

4. 9248318 - Optimization and feedback control of HIFU power deposition through the analysis of detected signal characteristics (2016-02-02),

5. 9144421 - Optimization of acoustic window and target depth for transabdominal ultrasound treatment or imaging of the uterus (2015-09-29),

6. 9050449 - System for treating a volume of tissue with high intensity focused ultrasound (2015-06-09),

7. 8845559 - Method and apparatus for treating tissues with HIFU (2014-09-30),

8. 8480600 - Method and apparatus for feedback control of HIFU treatments (2013-07-09),

9. 8439907 - Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient (2013-05-14),

10. 8277379 - Methods and apparatus for the treatment of menometrorrhagia, endometrial pathology, and cervical neoplasia using high intensity focused ultrasound energy (2012-10-02),

11. 8216161 - Optimization and feedback control of HIFU power deposition through the frequency analysis of backscattered HIFU signals (2012-07-10),

12. 8187270 - Hemostatic spark erosion tissue tunnel generator with integral treatment providing variable volumetric necrotization of tissue (2012-05-29),

13. 8057391 - Apparatus for delivering high intensity focused ultrasound energy to a treatment site internal to a patient's body (2011-11-15),

14. 8052604 - Methods and apparatus for engagement and coupling of an intracavitory imaging and high intensity focused ultrasound probe (2011-11-08),

15. 7722539 - Treatment of unwanted tissue by the selective destruction of vasculature providing nutrients to the tissue (2010-05-25),

Company Overview

Mirabilis Medica, Inc. is a biotechnology company based in Bothell, Washington, specializing in the development of innovative medical therapies. The organization focuses on advancing treatments for various health conditions through its proprietary technologies. With a commitment to improving patient outcomes, Mirabilis Medica leverages its expertise in drug development and delivery systems to address unmet medical needs. The company aims to enhance therapeutic efficacy and safety, contributing to the evolving landscape of healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#36 in Bothell, WA

#458 in Washington

#21,052 in US

#39,921 in the World

Bothell, WA, United States of America

Mirabilis Medica, Inc.

Forward Citations = 1,302

30 inventors:

Gregory Paul Darlington (9 out of 21 patents)

Michael J Connolly (8 out of 38 patents)

Justin Reed (6 out of 9 patents)

4. Jessica E Parsons (5 out of 5 patents)

5. Charles Dale Emery (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mirabilis Medica, Inc.. Retrieved from https://idiyas.com/company/mirabilis-medica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…